Merrill Lynch
-
Vertex Pharma (VRTX) Prices $375M Senior Subordinated Notes Offering
-
Vertex Pharma (VRTX) Announces $375M Senior Subordinated Notes Offering
-
Vertex Pharma (VRTX) Announces Exercise of Over Allotment Option by Underwriters; Sees $500.5M in Gross Proceeds
-
Vertex Pharma (VRTX) Prices 11.5M Shares at $38.50/Share
-
Vertex Pharmaceuticals (VRTX) To Offer 9M Shares
